<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01592799</url>
  </required_header>
  <id_info>
    <org_study_id>114004</org_study_id>
    <nct_id>NCT01592799</nct_id>
  </id_info>
  <brief_title>Study on the Burden of Influenza-related Hospitalizations and Emergency Room (ER) Visits in Children in Spain</brief_title>
  <official_title>Burden of Influenza-related Hospitalizations and ER Visits in Children in Spain</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>GlaxoSmithKline</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>GlaxoSmithKline</source>
  <brief_summary>
    <textblock>
      This study aims to quantify the inpatient and ER visits burden of laboratory-confirmed
      influenza, and compare the clinical features, severity, complications, risk factors and
      socioeconomic impact of influenza in children presenting with acute respiratory illness (ARI)
      and/or isolated fever, with or without laboratory-confirmed influenza.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The total medical cost associated with each hospitalization or ER visit will also be
      calculated at the end of this study.

      The study will be conducted from October, 2010, until May, 2011. Each subject will be
      followed-up for 21-30 days via telephone. The follow-up medical chart review will preferably
      be performed within 7 days after the telephone contact.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2010</start_date>
  <completion_date type="Actual">May 2011</completion_date>
  <primary_completion_date type="Actual">May 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Laboratory-confirmed influenza in children presenting with ARI and/or isolated fever</measure>
    <time_frame>Day 0 till Day 28-37</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Direct medical cost per hospitalization or ER visit with laboratory-confirmed influenza</measure>
    <time_frame>Day 0 till Day 28-37</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Laboratory-confirmed respiratory viruses in children presenting with ARI and/or isolated fever</measure>
    <time_frame>Day 0 till Day 28-37</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Occurrence of death</measure>
    <time_frame>Day 0 till Day 28-37</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Occurrence of secondary bacterial infections</measure>
    <time_frame>Day 0 till Day 28-37</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Potential risk factors</measure>
    <time_frame>Day 0 till Day 28-37</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of days of hospitalization</measure>
    <time_frame>Day 0 till Day 28-37 (between October 2010 until May 2011)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Use of medication</measure>
    <time_frame>Day 0 till Day 28-37</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of days of school absenteeism</measure>
    <time_frame>Day 0 till Day 28-37</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of days of parent or caregiver time off work</measure>
    <time_frame>Day 0 till Day 28-37</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of household members with influenza-like illness</measure>
    <time_frame>Day 0 till Day 28-37</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">501</enrollment>
  <condition>Influenza</condition>
  <arm_group>
    <arm_group_label>Influenza Group</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Children &lt;15 years of age hospitalized for or presenting to an ER for acute ARI and/or isolated fever during the influenza season.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Throat swab and/or nasopharyngeal swab</intervention_name>
    <description>Samples will be tested to quantify the inpatient and ER visits burden of laboratory-confirmed influenza.</description>
    <arm_group_label>Influenza Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Data collection</intervention_name>
    <description>Log Sheet will be used to collected data on a monthly basis for the following age groups: &lt; 6 months; 6-23 months; 24-59 months; &gt; 5 years.</description>
    <arm_group_label>Influenza Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subjects for whom the investigator believes that they and/or their parents/guardians
             can and will comply with the requirements of the protocol.

          -  A male or female &lt;15 years of age at the time of study entry. A subject will become
             ineligible on his/her 15th birthday.

          -  Signed informed consent from the parents or guardians of the subject and signed assent
             from children ≥ 12 years old.

          -  Presenting with a sudden onset clinical process comprising :

               -  Isolated fever defined as: oral temperature ≥ 37.5°C / axillary temperature ≥
                  37.5°C / Rectal temperature ≥ 38°C / tympanic temperature on oral setting ≥
                  37.5°C / tympanic temperature on rectal setting ≥ 38°C without an obvious cause.

        And/or

          -  ARI defined as one or more of the following symptoms: sore throat, coryza, cough,
             breathing difficulties.

        Exclusion Criteria:

        • Children in foster care.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>15 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>GSK Clinical Trials</last_name>
    <role>Study Director</role>
    <affiliation>GlaxoSmithKline</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Bilbao</city>
        <zip>48013</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>May 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 3, 2012</study_first_submitted>
  <study_first_submitted_qc>May 3, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 7, 2012</study_first_posted>
  <last_update_submitted>May 3, 2012</last_update_submitted>
  <last_update_submitted_qc>May 3, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 7, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Influenza</keyword>
  <keyword>Children</keyword>
  <keyword>Hospitalizations</keyword>
  <keyword>Spain</keyword>
  <keyword>Burden</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Influenza, Human</mesh_term>
  </condition_browse>
  <pending_results>
    <submitted>September 20, 2017</submitted>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

